Powered by
-
BMY Stock Chart
Historical BMY Prices
Bristol-Myers Squibb Stock Analysis
Rating: Hold
Total Grade: C
Analysis Breakdown
| BMY Stock Grade: | C |
| Fundamental Grade: | C |
| Quantitative Grade: | D |
| BMY Earnings | |
| Earnings Growth: | F |
| Earnings Momentum: | A |
| Earnings Surprises: | B |
| Analyst Earnings Revisions: | B |
| BMY Financial Information | |
| Sales Growth: | C |
| Operating Margin Growth: | F |
| Cash Flow: | C |
| Return on Equity: | C |
Bristol-Myers Squibb Stock: Weekly View
| This Week: | C |
|---|---|
| Last Week: | C |
| Two Weeks Ago: | C |
BMY Stock predictions, Articles, and Bristol-Myers Squibb News
- From InvestorPlace
- From the Web
-
5 Big Pharma Stocks Investors Love Right Now - July 13, 2018
The biotechnology and pharmaceutical sectors continue to offer great value for investors, and these five Big Pharma stocks stand out from the crowd. Continue…
-
Why Bristol-Myers Squibb Company Shares Are Down Today - June 4, 2018
Bristol-Myers Squibb Company (BMY) shares were sliding as the company's collaboration cancer drug with Nektar Therapeutics (NKTR) did not impress investors. Continue…
-
Why Nektar Therapeutics Shares Are Plunging Today - June 4, 2018
Nektar Therapeutics (NKTR) took a heavy hit on Monday following the release of preliminary results from a recent clinical trial. Continue…
-
Pfizer Inc. Stock Is Boring But Great for Your Portfolio’s Health - May 1, 2018
Fundamentally PFE is too cheap. So go long on this earnings dip inside a nervous market. Management is proven for decades and is bankable for the future. Continue…
-
Bristol-Myers Squibb Co Reports Earnings for First Quarter of 2018 - April 26, 2018
Bristol-Myers Squibb (BMY) released its earnings report for the first quarter of the year of Thursday and it was a mixed bag. Continue…
-
Stocks Push Forward As Fears of War Diminish - April 17, 2018
Stocks climbed again on Monday, shrugging off the U.S.-led airstrike on Syria over the weekend. Now the market will get an update on U.S. industrial production as well as a batch of Federal Reserve policymaker speeches. Continue…
-
5 Trades to Make First Thing Tomorrow Morning - April 16, 2018
On Monday we had be big moves from Bank of America, Starbucks, Ford and others. Here's 5 hot stocks to watch and what trades to make on Tuesday. Continue…
-
Mylan Stock is One Stumble Away From a Big Technical Pullback - March 21, 2018
Thinking about buying Mylan stock? You may not want to just yet. It's toying with a support line that, if it snaps, could open the selling floodgates. Continue…
-
At $65.63, Bristol-Myers Squibb Co (BMY) a Buy - March 2, 2018
At $65.63, Bristol-Myers Squibb Co (BMY) a Buy based on the latest stock market ratings, and comparative pricing of its shares. Continue…
-
Strong Quant Score Make Bristol-Myers Squibb Co (BMY) a Buy at recent price of $60.96 - February 6, 2018
The a Buy rating for BMY is based on the Portfolio Grader stock evaluator. The methodology for investing incorporated in this analytical tool researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. BMY has maintained this ranking for the last month. Continue…
